[go: up one dir, main page]

FI970069L - Förfarande för framställning av (2R,3S)-(4-asetoxi-2alfa-bensoyloxi-5beta, 20-epoxi-1,7beta,10beta-trihydroxi-9-oxotax-11-en-13alfa-yl)-3-tert-butoxikarbonylamino-3-fenyl-2-hydroxipropionattrihydrat - Google Patents

Förfarande för framställning av (2R,3S)-(4-asetoxi-2alfa-bensoyloxi-5beta, 20-epoxi-1,7beta,10beta-trihydroxi-9-oxotax-11-en-13alfa-yl)-3-tert-butoxikarbonylamino-3-fenyl-2-hydroxipropionattrihydrat Download PDF

Info

Publication number
FI970069L
FI970069L FI970069A FI970069A FI970069L FI 970069 L FI970069 L FI 970069L FI 970069 A FI970069 A FI 970069A FI 970069 A FI970069 A FI 970069A FI 970069 L FI970069 L FI 970069L
Authority
FI
Finland
Prior art keywords
oxotax
10beta
13alpha
5beta
7beta
Prior art date
Application number
FI970069A
Other languages
English (en)
Finnish (fi)
Other versions
FI970069A0 (sv
FI119246B (sv
Inventor
Jean-Rene Authelin
Jacques Doveze
Elie Fouque
Bernadette Mandard
Isabelle Taillepied
Original Assignee
Rhone Poulenc Rorer Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9465183&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI970069(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa
Publication of FI970069L publication Critical patent/FI970069L/sv
Publication of FI970069A0 publication Critical patent/FI970069A0/sv
Application granted granted Critical
Publication of FI119246B publication Critical patent/FI119246B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Epoxy Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
FI970069A 1994-07-08 1997-01-07 Förfarande för framställning av (2R,3S)-(4-asetoxi-2alfa-bensoyloxi-5b eta,20-epoxi-1,7beta,10beta-trihydroxi-9-oxotax-11-en-13alfa-yl)-3-tert-butoxikarbonylamino-3-fenyl-2-hydroxipropionattrihydrat FI119246B (sv)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
FR9408479A FR2722191B1 (fr) 1994-07-08 1994-07-08 Procede de preparation du trihydrate du (2r,3s)-3-tertbutoxycarbonylamino-2-hydroxy-3-phenylpropionate de 4-acetoxy2alpha-benzoyloxy-5beta,20epoxy-1,7beta,10beta trihydroxy-9-oxo-tax-11-en-13alpha-yle
FR9408479 1994-07-08
FR9500910 1995-07-07
PCT/FR1995/000910 WO1996001815A1 (fr) 1994-07-08 1995-07-07 PROCEDE DE PREPARATION DU TRIHYDRATE DU (2R,3S)-3-TERT-BUTOXYCARBONYLAMINO-2-HYDROXY-3-PHENYLPROPIONATE DE 4-ACETOXY-2α-BENZOYLOXY-5β,20-EPOXY-1,7β,10β-TRIHYDROXY-9-OXO-TAX-11-EN-13α-YLE

Publications (3)

Publication Number Publication Date
FI970069L true FI970069L (sv) 1997-01-07
FI970069A0 FI970069A0 (sv) 1997-01-07
FI119246B FI119246B (sv) 2008-09-15

Family

ID=9465183

Family Applications (1)

Application Number Title Priority Date Filing Date
FI970069A FI119246B (sv) 1994-07-08 1997-01-07 Förfarande för framställning av (2R,3S)-(4-asetoxi-2alfa-bensoyloxi-5b eta,20-epoxi-1,7beta,10beta-trihydroxi-9-oxotax-11-en-13alfa-yl)-3-tert-butoxikarbonylamino-3-fenyl-2-hydroxipropionattrihydrat

Country Status (38)

Country Link
US (1) US6022985A (sv)
EP (1) EP0770070B1 (sv)
JP (1) JP3753155B2 (sv)
KR (1) KR100391753B1 (sv)
CN (1) CN1067996C (sv)
AT (1) ATE171702T1 (sv)
AU (1) AU706519B2 (sv)
BR (1) BR9508789A (sv)
CA (1) CA2193531C (sv)
CO (1) CO4410189A1 (sv)
CZ (1) CZ284695B6 (sv)
DE (1) DE69505128T2 (sv)
DK (1) DK0770070T3 (sv)
DZ (1) DZ1905A1 (sv)
ES (1) ES2121404T3 (sv)
FI (1) FI119246B (sv)
FR (1) FR2722191B1 (sv)
GR (1) GR3027558T3 (sv)
HU (1) HU220634B1 (sv)
IL (1) IL114274A (sv)
IN (1) IN183947B (sv)
IS (1) IS2032B (sv)
MA (1) MA23606A1 (sv)
MX (1) MX9700173A (sv)
MY (1) MY118481A (sv)
NO (1) NO314500B1 (sv)
NZ (1) NZ289455A (sv)
PE (1) PE8697A1 (sv)
PL (1) PL179876B1 (sv)
RU (1) RU2126397C1 (sv)
SI (1) SI0770070T1 (sv)
SK (1) SK280520B6 (sv)
TN (1) TNSN95071A1 (sv)
TW (1) TW419473B (sv)
UA (1) UA51624C2 (sv)
UY (1) UY23991A1 (sv)
WO (1) WO1996001815A1 (sv)
ZA (1) ZA955646B (sv)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6638502B1 (en) 1997-04-28 2003-10-28 Gencell Sas Adenovirus-mediated intratumoral delivery of an angiogenesis antagonist for the treatment of tumors
SE510650C2 (sv) * 1997-05-30 1999-06-14 Astra Ab Ny förening
FR2794771B1 (fr) 1999-06-11 2001-08-10 Aventis Pharma Sa Adenovirus recombinants codant pour le transporteur specifique de l'iode (nis)
US6853921B2 (en) 1999-07-20 2005-02-08 Halliburton Energy Services, Inc. System and method for real time reservoir management
US6266619B1 (en) * 1999-07-20 2001-07-24 Halliburton Energy Services, Inc. System and method for real time reservoir management
GB9920548D0 (en) * 1999-08-31 1999-11-03 Rhone Poulenc Rorer Sa Treatment of hepatocellular carcinoma
US6891050B2 (en) * 2001-08-10 2005-05-10 Dabur India Limited Process for the preparation of taxanes such as paclitaxel, docetaxel and structurally similar analogs
US6881852B2 (en) * 2002-02-05 2005-04-19 Dabur India Limited Process of purification of paclitaxel and docetaxel
US7247738B2 (en) * 2002-05-07 2007-07-24 Dabur India Limited Method of preparation of anticancer taxanes using 3-[(substituted-2-trialkylsilyl) ethoxycarbonyl]-5-oxazolidine carboxylic acids
US6900342B2 (en) * 2002-05-10 2005-05-31 Dabur India Limited Anticancer taxanes such as paclitaxel, docetaxel and their structural analogs, and a method for the preparation thereof
US6838569B2 (en) * 2002-12-16 2005-01-04 Dabur India Limited Process for preparation of paclitaxel trihydrate and docetaxel trihydrate
US7584165B2 (en) * 2003-01-30 2009-09-01 Landmark Graphics Corporation Support apparatus, method and system for real time operations and maintenance
US8703982B2 (en) * 2003-03-17 2014-04-22 Phyton Holdings Llc Purification of taxanes
CN1268619C (zh) * 2003-05-08 2006-08-09 上海迪赛诺化学制药有限公司 多烯紫杉醇三水化合物的制备方法
DE602004020506D1 (de) 2003-12-12 2009-05-20 Quiral Quimica Do Brasil Verfahren zur herstellung von wasserfreien und hydratisierten pharmazeutischen wirkstoffen (apis); aus diesen hergestellte stabile pharmazeutische zusammensetzungen und anwendungen für diese zusammensetzungen
US7142986B2 (en) * 2005-02-01 2006-11-28 Smith International, Inc. System for optimizing drilling in real time
CN100420681C (zh) * 2005-04-29 2008-09-24 上海奥锐特国际贸易有限公司 多烯紫杉醇三水物的制备方法
RU2433818C2 (ru) 2005-08-31 2011-11-20 АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи Композиции, включающие слаборастворимые в воде фармацевтические вещества и противомикробные вещества
EP1928435B8 (en) * 2005-08-31 2019-03-20 Abraxis BioScience, LLC Compositions of poorly water soluble drugs with increased stability and methods for preparation thereof
TW200730518A (en) * 2005-10-12 2007-08-16 Sicor Inc Crystalline forms of docetaxel and processes for their preparation
KR100995390B1 (ko) 2006-01-02 2010-11-19 주식회사 삼양제넥스 무정형, 무수결정형 또는 수화 결정형 도세탁셀의 제조방법
MX2008009308A (es) * 2006-01-20 2008-10-03 Landmark Graphics Corp Administracion del sistema de produccion dinamica.
KR20080100264A (ko) * 2006-03-21 2008-11-14 닥터 레디스 레보러터리즈 리미티드 도세탁셀의 다형체와 그 제조방법
CN101534642A (zh) * 2006-10-20 2009-09-16 神隆药业新加坡私人有限公司 用于制备结晶无水多西紫杉醇的方法
KR100868116B1 (ko) * 2007-04-09 2008-11-10 한미약품 주식회사 도세탁셀·모노프로필렌글라이콜 내포화합물 및 이의제조방법
KR100878455B1 (ko) * 2007-04-10 2009-01-13 한미약품 주식회사 안정한 무수결정형 도세탁셀 및 이의 제조방법
EP2173732A4 (en) * 2007-07-04 2011-09-07 Reddys Lab Ltd Dr PROCESSES FOR THE PREPARATION OF DOCETAXEL AND POLYMORPHIC
EP2080763A1 (en) * 2008-01-18 2009-07-22 INDENA S.p.A. Crystalline form I of ortataxel
EP2080764B1 (en) * 2008-01-18 2012-08-22 INDENA S.p.A. Solid forms of ortataxel
PL388144A1 (pl) 2009-05-29 2010-12-06 Przedsiębiorstwo Produkcyjno-Wdrożeniowe Ifotam Spółka Z Ograniczoną Odpowiedzialnością Solwaty (2R,3S)-3-tert-butoksykarbonylamino-2-hydroksy-3-fenylopropionianu 4-acetoksy-2α-benzoiloksy -5β,20-epoksy-1,7β,10β-trihydroksy-9-okso-taks-11-en-13α-ylu, sposób ich otrzymywania i zastosowanie
ES2621613T3 (es) 2009-11-04 2017-07-04 Emcure Pharmaceuticals Limited Un proceso mejorado para la preparación de derivados de taxano
NZ603828A (en) 2010-05-03 2015-09-25 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
WO2012160568A1 (en) * 2011-05-23 2012-11-29 Shilpa Medicare Limited Process for preparing docetaxel trihydrate polymorph
CA2846372C (en) 2011-09-08 2021-01-12 New York University Oncolytic herpes simplex virus and therapeutic uses thereof
WO2013096455A1 (en) 2011-12-20 2013-06-27 Dana-Farber Cancer Institute, Inc. Methods for diagnosing and treating oncogenic kras-associated cancer
EA031986B1 (ru) 2012-04-04 2019-03-29 Галозим, Инк. Способ и комбинация для лечения солидной раковой опухоли и набор, содержащий комбинацию
WO2013177426A2 (en) 2012-05-24 2013-11-28 Dana-Farber Cancer Institute, Inc. Targeting the glutamine to pyruvate pathway for treatment of oncogenic kras-associated cancer
US20150285802A1 (en) 2012-07-18 2015-10-08 Dana-Farber Cancer Institute, Inc. Methods for treating, preventing and predicting risk of developing breast cancer
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
EP2968406A4 (en) 2013-03-14 2016-10-26 Icahn School Med Mount Sinai WITH AUTOLOGOUS TUMORLYSAT-LOADED DENDRITIC CELL VACCINE FOR THE TREATMENT OF LIVER CANCER
WO2015050844A1 (en) 2013-10-01 2015-04-09 Dana-Farber Cancer Institute, Inc. Methods of treating cancer with atovaquone-related compounds
WO2015149006A2 (en) 2014-03-27 2015-10-01 Dana-Farber Cancer Institute, Inc. Compositions and methods for modulating ncoa4-mediated autophagic targeting of ferritin
MA39818A (fr) 2014-03-30 2017-02-08 Benevir Biopharm Inc Virus oncolytiques « armés » comprenant un inhibiteur de tap exogène et leurs utilisations thérapeutiques
EP3307330B1 (en) 2015-06-15 2021-03-10 New York University Method of treatment using oncolytic viruses
US20190351031A1 (en) 2018-05-16 2019-11-21 Halozyme, Inc. Methods of selecting subjects for combination cancer therapy with a polymer-conjugated soluble ph20

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2601675B1 (fr) * 1986-07-17 1988-09-23 Rhone Poulenc Sante Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent
US5229526A (en) * 1991-09-23 1993-07-20 Florida State University Metal alkoxides

Also Published As

Publication number Publication date
MY118481A (en) 2004-11-30
FR2722191A1 (fr) 1996-01-12
AU2930595A (en) 1996-02-09
CZ284695B6 (cs) 1999-02-17
DZ1905A1 (fr) 2002-02-17
IS2032B (is) 2005-08-15
SK280520B6 (sk) 2000-03-13
BR9508789A (pt) 1997-10-21
FI970069A0 (sv) 1997-01-07
FR2722191B1 (fr) 1996-08-23
KR970704721A (ko) 1997-09-06
MA23606A1 (fr) 1996-04-01
NO314500B1 (no) 2003-03-31
US6022985A (en) 2000-02-08
CN1067996C (zh) 2001-07-04
WO1996001815A1 (fr) 1996-01-25
IN183947B (sv) 2000-05-20
NZ289455A (en) 1997-12-19
CA2193531C (fr) 2006-12-05
MX9700173A (es) 1997-04-30
DE69505128D1 (de) 1998-11-05
PL318195A1 (en) 1997-05-26
UA51624C2 (uk) 2002-12-16
PE8697A1 (es) 1997-03-26
TNSN95071A1 (fr) 1996-02-06
AU706519B2 (en) 1999-06-17
GR3027558T3 (en) 1998-11-30
HU9700041D0 (en) 1997-02-28
IL114274A (en) 1999-04-11
JP3753155B2 (ja) 2006-03-08
NO970007L (no) 1997-01-02
KR100391753B1 (ko) 2004-02-11
PL179876B1 (pl) 2000-11-30
IL114274A0 (en) 1995-10-31
CZ3597A3 (en) 1997-04-16
CO4410189A1 (es) 1997-01-09
UY23991A1 (es) 1995-09-20
EP0770070B1 (fr) 1998-09-30
ZA955646B (en) 1996-02-21
SI0770070T1 (en) 1998-12-31
RU2126397C1 (ru) 1999-02-20
TW419473B (en) 2001-01-21
HUT76833A (en) 1997-11-28
DK0770070T3 (da) 1999-03-01
ES2121404T3 (es) 1998-11-16
JPH10502627A (ja) 1998-03-10
FI119246B (sv) 2008-09-15
SK697A3 (en) 1997-06-04
CN1151741A (zh) 1997-06-11
ATE171702T1 (de) 1998-10-15
NO970007D0 (no) 1997-01-02
DE69505128T2 (de) 1999-04-01
EP0770070A1 (fr) 1997-05-02
HU220634B1 (hu) 2002-03-28
CA2193531A1 (fr) 1996-01-25
IS4411A (is) 1997-01-07

Similar Documents

Publication Publication Date Title
FI970069L (sv) Förfarande för framställning av (2R,3S)-(4-asetoxi-2alfa-bensoyloxi-5beta, 20-epoxi-1,7beta,10beta-trihydroxi-9-oxotax-11-en-13alfa-yl)-3-tert-butoxikarbonylamino-3-fenyl-2-hydroxipropionattrihydrat
IT1268340B1 (it) Macchina per la fabbricazione di granite.
FI964441L (sv) Föreningar, som är användbara vid behandling av retrovirusinfertioner
NO903190L (no) Fremgangsmaate for klorering av sukrose-b-estere.
NO20002443D0 (no) FremgangsmÕte for fremstilling av derivater av taxoidklassen
NO20004738D0 (no) FremgangsmÕte for fremstilling av et epoksyd
FI951903L (sv) Förfarande för framställning av ginkgolid B ur ginkolid C
ID17723A (id) Senyawa untuk pengobatan
EP1023250A4 (en) METHOD FOR PRODUCING 2,6-DIALKYLNAPHTHALINE
FI963452L (sv) Förfarande för framställning av epoxid
NO995851D0 (no) Fremstillingsfremgangsmåte for isoksasolidinedion forbindelse
FI973105L (sv) Förfarande för framställning av (4,10-diacetoxi-2alfa-bensoyloxi-5beta,20epoxi-1,7beta-dihydroxi-9-oxotax-11-en-13alfa-yl)-(2R,3S)-3-bensoylamino-3-fenyl-2-hydroxipropionaattrihydrat
FI902336A0 (fi) Anordning foer framstaellning av en fristaoende kiselkristall.
FI101472B1 (sv) Förfarande för framställning av monoestrar av 1,3-dioler
TR199800403A3 (tr) a-Bromo-laktam türevlerinin hazirlanmasi için yöntem.
MX9202076A (es) Proceso de hidroconversion novedoso.
NO985535D0 (no) FremgangsmÕte for fremstilling av 1,3-alkandioler
FI964410L (sv) Förfarande för framställning av 4-amino-delta4-3-ketosteroider genom 4-nitro-delta4-3-ketosteroider
FI965228L (sv) Förfarande för framställning av 1,4-butandiol
TR199700863A3 (tr) Paklitaksel hazirlama prosesi.
IT241651Y1 (it) Macchina perfezionata per la produzione di granita.
NO20005743L (no) Fremgangsmåte til fremstilling av 4,5-epoksymorfinan-6- glukuronider
DE19581745T1 (de) Verkapselungsverfahren
FI970039L (sv) Förfarande för framställning av 5-aryl-2,4-dialkyl-3H-1,2,3-triazol-3-tioner
FI951441L (sv) Förfarande för framställning av 5-formylamino-pyrimidiner

Legal Events

Date Code Title Description
FG Patent granted

Ref document number: 119246

Country of ref document: FI

MA Patent expired